Theralase Technologies Inc. (CVE:TLT – Get Free Report)’s share price shot up 13.2% on Thursday. The company traded as high as C$0.22 and last traded at C$0.21. 284,162 shares were traded during trading, an increase of 20% from the average daily volume of 236,993 shares. The stock had previously closed at C$0.19.
Theralase Technologies Stock Up 15.8%
The firm has a 50 day moving average price of C$0.18 and a two-hundred day moving average price of C$0.23. The company has a current ratio of 5.48, a quick ratio of 3.40 and a debt-to-equity ratio of 2.17. The firm has a market capitalization of C$68.31 million, a price-to-earnings ratio of -15.71 and a beta of -1.01.
About Theralase Technologies
Theralase Technologies Inc, a clinical stage pharmaceutical company, engages in the research and development of light activated photo dynamic compounds (PDCs) and their associated drug formulations to treat cancers, bacteria, and viruses in Canada, the United States, and internationally. It also designs, develops, manufactures, and markets patented and proprietary super-pulsed laser technology for the healing of chronic knee pain, as well as for off-label use to heal various nerve, muscle, and joint conditions.
Featured Stories
- Five stocks we like better than Theralase Technologies
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Theralase Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Theralase Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
